Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

A woman with severe angioedema improved significantly after treatment with rituximab.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

A child's chronic use of Senna caused liver damage and a severe decrease in blood cells, but improved after stopping Senna and getting treatment.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

New understanding and treatments for hair loss are improving, but more research is needed.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.